Work-related productivity losses in an era of ageing populations: The case of colorectal cancer

Journal of Occupational and Environmental Medicine

Volumn 55, Issue 2, 2013, Pages 128-134

  Hanly, Paul ^a   Walsh, Paul M ^a   Ó Céilleachair, Alan ^a   Skally, Mairead ^a   Staines, Anthony ^b   Kapur, Kanika ^c   Fitzpatrick, Patricia ^c   Sharp, Linda ^a  

^a NATIONAL CANCER REGISTRY IRELAND   (Ireland)

^b DUBLIN CITY UNIVERSITY   (Ireland)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGING; ARTICLE; CANCER SURVIVAL; CANCER SURVIVOR; COLORECTAL CANCER; COST; FEMALE; HEALTH SURVEY; HUMAN; IRELAND; MAJOR CLINICAL STUDY; MALE; POSTAL MAIL; PRODUCTIVITY; RETIREMENT; WORKMAN COMPENSATION;

AGE FACTORS; AGED; AGING; COLORECTAL NEOPLASMS; EFFICIENCY; EMPLOYMENT; FEMALE; HUMANS; IRELAND; MALE; MIDDLE AGED; MORTALITY, PREMATURE; QUESTIONNAIRES; RETIREMENT; SEX FACTORS; SICK LEAVE; SURVIVORS;

EID: 84873997512     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0b013e3182820553     Document Type: Article

References (38)

1. Ferlay J, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46:765-781.
2. Kanavos P, Schurer W. The dynamics of colorectal cancer management in 17 countries. Eur J Health Econ. 2010;10:S115-S129.
3. Maddams J, Brewster D, Gavin A, et al. Cancer prevalence in the United Kingdom: estimates for 2008. Br J Cancer. 2009;101:541-547.
4. Carsi AE, Sharp L, Cronin-Fenton DP, Ó Céilleachair A, Comber H. Inequity in colorectal cancer treatment and outcomes: a population-based study. Br J Cancer. 2008;99:266-274.
5. Gordon L, Lynch BM, Newman B. Transitions in work participation after a diagnosis of colorectal cancer. Aust N Z J Public Health. 2008;32:569-574.
6. Bains M, Munir F, Yarker J, et al. The impact of colorectal cancer and selfefficacy beliefs on work ability and employment status: a longitudinal study. Eur J Cancer Care (Engl). 2012;21:634-641.
7. Sharp L, Timmons A. Social welfare and legal constraints associated with work among breast and prostate cancer survivors: experiences from Ireland. J Cancer Surviv. 2011;5:382-394.
8. Bojke L, Spackman E,Hinde S, Helliwell P. Capturing all of the costs inNICE appraisals: the impact of inflammatory rheumatic diseases on productivity. Rheumatology (Oxford). 2012;51:210-215.
9. Ó Céilleachair A, Hanly P, O'Neill C, et al. Cost comparisons and methodological heterogeneity in cost-of-illness studies: the example of colorectal cancer. Med Care. In Press.
10. Tilson L, Sharp L, Usher C, et al. Cost of care for colorectal cancer in Ireland: a health care payer perspective. Eur J Health Econ. 2012;13:511-524.
11. Lidgren M, Wilking N, J̈onsson B. Cost of breast cancer in Sweden in 2002. Eur J Health Econ. 2007;8:5-15.
12. Broekx S, Hond E, Torfs R, et al. The costs of breast cancer prior to and following diagnosis. Eur J Health Econ. 2010;12:311-317.
13. Tingstedt B, Andersson E, Flink A, Bolin K, Lindgren B, Andersson R. Pancreatic cancer, healthcare cost, and loss of productivity: a register-based approach. World J Surg. 2011;35:2298-2305.
14. Selke B, Durand I, Marissal JP, Chevalier D, Lebrun T. Cost of colorectal cancer in France in 1999 [in French]. Gastroenterol Clin Biol. 2003;27:22-27.
15. Chomik R, Whitehouse ER. Trends in Pension Eligibility Ages and Life Expectancy, 1950-2050. http://www.oecd-ilibrary.org/social-issues- migrationhealth/trends-in-pension-eligibility-ages-and-life-expectancy-1950- 2050-5km68fzhs2q4-en. Accessed April 23, 2012. Published 2010.
16. Health Information and Quality Authority. Guidelines for the economic evaluation of health technologies in Ireland. http://www.hiqa.ie/publication/ guidelines-economic-evaluation-health-technologies-ireland. Published 2010. Accessed February 17, 2011.
17. Ó Céilleachair A, Costello L, Finn C, et al. Inter-relationships between the economic and emotional consequences of colorectal cancer for patients and their families: A qualitative study. BMC Gastroenterol. 2012;12:62.
18. Central Statistics Office. Quarterly National Household Survey. Dublin, Ireland: Central Statistics Office; 2011.
19. Bergin A, Conefrey T, Gerald JF, Kearney I. Recovery Scenarios for Ireland. Economic and Social Research Institute: Research Series. Issue 7. May 2009.
20. Krol M, Papenburg J, Koopmanschap M, Brouwer W. Do productivity costs matter? The impact of including productivity costs on the incremental costs of interventions targeted at depressive disorders. Pharmacoeconomics. 2011;29:601-619.
21. Hanly P, Timmons A, Walsh PM, Sharp L. Breast and prostate cancer productivity costs: A comparison of the human capital approach and the friction cost approach. Value Health. 2012;15:429-436.
22. Brenner H, Rachet B. Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases. Eur J Cancer. 2004;40:2494-2501.
23. Kelly M, Sharp L, Dwane F, Kelleher T, Comber H. Factors predicting hospital length-of-stay and readmission after colorectal resection: a populationbased study of elective and emergency admissions. BMC Health Serv Res. 2012;12:77.
24. Mehnert A. Employment and work-related issues in cancer survivors. Crit Rev Oncol Hematol. 2011;77:109-130.
25. Sanchez KM, Richardson JL, Mason HR. The return to work experiences of colorectal cancer survivors. AAOHN J. 2004;52:500-510.
26. Earle CC, Chretien Y, Morris C, et al. Employment among survivors of lung cancer and colorectal cancer. J Clin Oncol. 2010;28:1700-1705.
27. Bradley CJ, Yabroff KR, Dahman B, Feuer EJ, Mariotto A, Brown ML. Productivity costs of cancer mortality in the United States: 2000-2020. J Natl Cancer Inst. 2008;100:1763-1770.
28. National Cancer Registry Ireland. Cancer in Ireland: Annual Report of the National Cancer Registry. Cork, Ireland: National Cancer Registry Ireland; 2011.
29. Kim SG, Hahm MI, Choi KS, Seung NY, Shin HR, Park EC. The economic burden of cancer in Korea in 2002. Eur J Cancer Care (Engl). 2008;17:136-144.
30. Bradley CJ, Lansdorp-Vogelaar I, Yabroff KR, et al. Productivity savings from colorectal cancer prevention and control strategies. Am J Prev Med. 2011;41:e5-e14.
31. Eurostat/European Commission. Active ageing and solidarity between generations-A statistical portrait of the European Union 2012. http://epp.eurostat.ec.europa.eu/portal/page/portal/product details/publication? p product code=KS-EP-11-001. Accessed May 4, 2012.
32. Department of Social Protection, Pension. http://www.welfare.ie/EN/ Schemes/Pension/Pages/default.aspx. Accessed April 20, 2012.
33. Morris S, Cox B, Bosanquet N. Cost of skin cancer in England. Eur J Health Econ. 2009;10:267-273.
34. Bradley CJ, Neumark D, Luo Z, SchenkM. Employment and cancer: findings from a longitudinal study of breast and prostate cancer survivors. Cancer Invest. 2007;25:47-54.
35. Amir Z, Moran T, Walsh L, Iddenden R, Luker K. Return to paid work after cancer: a British experience. J Cancer Surviv. 2007;1:129-136.
36. Oberst K, BradleyCJ, Gardiner JC, SchenkM,GivenCW.Work task disability in employed breast and prostate cancer patients. J Cancer Surviv. 2010;4:322-330.
37. Tranmer JE, Guerriere DN, Ungar WJ, Coyte PC. Valuing patient and caregiver time: a review of the literature. Pharmacoeconomics. 2005;23:449-459.
38. Johannesson M, Karlsson G. The friction cost method: a comment. J Health Econ. 1997;16:249-255.